New arrangements for migalastat (Galafold®) for treatment of Fabry Disease

This fact sheet is for current and future patients with Fabry disease explaining how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS. It provides further clarity on future access arrangements via the PBS.

Cover page for the New arrangements for migalastat (Galafold) – patient fact sheet.

Downloads

New arrangements for migalastat (Galafold) – patient fact sheet

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Fact sheet
Audience:
General public
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.